Lv51
1170 积分 2021-03-31 加入
Beyond Bioisosteres: Impact of Replacing a Benzene Ring with sp 3 -Rich Three-Dimensional Saturated Bridged Bicyclic Match Pairs on Biotransformation, Metabolic Stability, and Other ADME Profiles
8天前
已完结
HumanBase: an interactive AI platform for human biology
2个月前
已完结
Safety, tolerability, and pharmacokinetics of lisaftoclax (APG-2575)-based therapy in patients with chronic lymphocytic leukemia: Phase 1b/2 study
6个月前
已完结
Efficacy and safety of OB756 (a novel selective JAK2 inhibitor) for essential thrombocythemia in patients intolerant of or resistant to hydroxyurea or intolerant of interferon: A phase 2, open‐label, multicenter study
6个月前
已完结
A phase 2 study of simtuzumab in patients with primary, post‐polycythaemia vera or post‐essential thrombocythaemia myelofibrosis
7个月前
已完结
Phase 1b and Dose-Expansion Study of GSK3326595, a PRMT5 Inhibitor as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cancers
7个月前
已完结
The discovery of novel and potent indazole NLRP3 inhibitors enabled by DNA-encoded library screening
7个月前
已完结
A Phase I Clinical Study and In Vivo Findings with PT-112, a Novel Immunogenic Cell Death-Inducing Small Molecule, in Relapsed or Refractory Multiple Myeloma
8个月前
已完结
A First-in-Class JAK/ROCK Inhibitor, Rovadicitinib in Patients with Myelofibrosis who were Refractory or Relapsed or Intolerant to Ruxolitinib: A Single-Arm, Multicenter, Open-Label, Phase Ib Study
8个月前
已完结
Phase 1 First-in-Human Dose-Expansion Study of The Oral SF3B1 Modulator H3B‑8800 In Lower-Risk Myelodysplastic Syndrome
9个月前
已完结
皖公网安备34019202002308
